Fontus Pharmaceuticals Inc., Roche deal

Fontus acquired U.S. rights to Rocaltrol calcitriol from Roche for an undisclosed sum. Rocaltrol was first approved in the U.S. in 1978 and is now indicated to treat secondary hyperparathyroidism in p...